⌘K

Home/Filings/4/0001127602-23-014564

4//SEC Filing

DeLuca Richard R. 4

Accession 0001127602-23-014564

CIK 0000310158other

View on SEC.gov Company Profile

Filed

May 3, 8:00 PM ET

Accepted

May 4, 6:14 PM ET

Size

6.6 KB

Accession

0001127602-23-014564

Insider Transaction Report

Form 4

Period: 2023-05-02

Merck & Co., Inc.MRK

DeLuca Richard R.

EVP&Pres, Merck Animal Health

Transactions

Award
Stock Option (Right to Buy)
2023-05-02+44,260→ 44,260 total
Exercise: $117.89From: 2024-05-02Exp: 2033-05-01→ Common Stock (44,260 underlying)

Holdings

Common Stock
154,492.854
Common Stock - 401(k) Plan
(indirect: By 401(k))
1,205.663

Footnotes (1)

[F1]The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1

filerCIK 0001421339

Filing Metadata

Form type: 4
Filed: May 3, 8:00 PM ET
Accepted: May 4, 6:14 PM ET
Size: 6.6 KB

View on SEC.gov